Processes

Fatty Liver

NAFLD/NASH - accumulation of fat in liver cells. Caused by insulin resistance, fructose excess, and choline deficiency.

Fatty Liver pathway diagram

Non-alcoholic fatty liver disease (NAFLD) encompasses a spectrum from simple steatosis (fat accumulation) to non-alcoholic steatohepatitis (NASH, with inflammation) to cirrhosis.

It affects 25-30% of adults globally and is the most common chronic liver disease.

Causes: Insulin resistance (primary driver - impairs fat oxidation, promotes lipogenesis), Excess fructose (promotes de novo lipogenesis in liver), Choline deficiency (impairs VLDL export of fat from liver), Omega-6/omega-3 imbalance, Gut dysbiosis (endotoxemia), and Genetic factors (PNPLA3 variants).

Progression: Simple steatosis (>5% fat) - often benign and reversible.

NASH - inflammation and hepatocyte damage, can progress. Fibrosis - scarring from chronic inflammation. Cirrhosis - severe scarring, liver failure risk. Hepatocellular carcinoma - cancer risk increases.

Nutrient factors: Choline - essential for phosphatidylcholine and VLDL assembly; deficiency directly causes fatty liver.

Betaine - supports choline pathways. Omega-3s - reduce liver fat and inflammation. Vitamin E - reduces NASH inflammation in studies. Milk thistle (silymarin) - hepatoprotective effects.

Treatment: Weight loss (even 5-10% helps), Exercise, Reduce fructose and refined carbs, Address insulin resistance, Choline/betaine supplementation, Omega-3s (EPA particularly), and possibly vitamin E (for NASH).

No approved drugs specifically for NAFLD yet.

Fatty Liver Discussion